Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer

Despite the tremendous progress in breast cancer diagnosis and treatment, the mortality rate is expected to increase due to the emergence of drug resistance. Pro-inflammatory markers are thought to contribute to drug resistance by activation of its naive receptors and its downstream signaling pathwa...

Full description

Saved in:
Bibliographic Details
Main Authors: Emdormi Rymbai (Author), Deepa Sugumar (Author), Jubie Selvaraj (Author), Ram Kothandam (Author), Divakar Selvaraj (Author)
Format: Book
Published: Tabriz University of Medical Sciences, 2023-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!